MetaADEDB 2.0 @ LMMD
fesoterodine
(MWHXMIASLKXGBU-RNCYCKTQSA-N)
Structure
SMILES
OC(=O)/C=C/C(=O)O.OCc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)OC(=O)C(C)C
Molecular Formula:
C30H41NO7
Molecular Weight:
527.649
Log P:
5.0929
Hydrogen Bond Acceptor:
8
Hydrogen Bond Donor:
3
TPSA:
124.37
CAS Number(s):
286930-03-8
Synonym(s)
1.
fesoterodine
2.
fesoterodine fumarate
3.
toviaz
External Link(s)
MeSHC526675
PubChem Compound9849808
BindingDB50248002
CHEMBLCHEMBL1201765
KEGGdr:D08923
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 695
Canada Vigilance: 23
Canada Vigilance
US FAERS
2Urinary RetentionFAERS: 283
Canada Vigilance: 19
Canada Vigilance
US FAERS
3ConstipationFAERS: 205
Canada Vigilance: 5
Canada Vigilance
US FAERS
4Drug effect incompleteFAERS: 137US FAERS
5DizzinessFAERS: 120
Canada Vigilance: 6
Canada Vigilance
US FAERS
6DysuriaFAERS: 96
Canada Vigilance: 2
Canada Vigilance
US FAERS
7MalaiseFAERS: 73
Canada Vigilance: 1
Canada Vigilance
US FAERS
8HeadacheFAERS: 64
Canada Vigilance: 1
Canada Vigilance
US FAERS
9Urinary IncontinenceFAERS: 62US FAERS
10NauseaFAERS: 60
Canada Vigilance: 3
Canada Vigilance
US FAERS
11FatigueFAERS: 52US FAERS
12PainFAERS: 48US FAERS
13SomnolenceFAERS: 48
Canada Vigilance: 1
Canada Vigilance
US FAERS
14Feeling abnormalFAERS: 46US FAERS
15DyspepsiaFAERS: 37
Canada Vigilance: 1
Canada Vigilance
US FAERS
16NocturiaFAERS: 37US FAERS
17Urinary tract infectionFAERS: 34
Canada Vigilance: 2
Canada Vigilance
US FAERS
18Abdominal discomfortFAERS: 33
Canada Vigilance: 2
Canada Vigilance
US FAERS
19DementiaFAERS: 32US FAERS
20Abdominal PainFAERS: 30US FAERS
21AstheniaFAERS: 28US FAERS
22Back PainFAERS: 28
Canada Vigilance: 2
Canada Vigilance
US FAERS
23PruritusFAERS: 28US FAERS
24VomitingFAERS: 27
Canada Vigilance: 1
Canada Vigilance
US FAERS
25Oropharyngeal painFAERS: 26US FAERS
26Cerebrovascular accidentFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
27Memory impairmentFAERS: 24US FAERS
28Wrong technique in drug usage processFAERS: 24US FAERS
29GlaucomaFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
30HypersensitivityFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
31AlopeciaFAERS: 21US FAERS
32DysphoniaFAERS: 21US FAERS
33UrticariaFAERS: 21US FAERS
34CystitisFAERS: 19US FAERS
35PalpitationsFAERS: 19US FAERS
36Bladder painFAERS: 18US FAERS
37Diabetes MellitusFAERS: 18US FAERS
38FlatulenceFAERS: 18US FAERS
39Chest PainFAERS: 16US FAERS
40HypotensionFAERS: 16
Canada Vigilance: 2
Canada Vigilance
US FAERS
41Incorrect dose administeredFAERS: 16US FAERS
42Lip swellingFAERS: 16US FAERS
43NasopharyngitisFAERS: 16US FAERS
44Product use issueFAERS: 16
Canada Vigilance: 2
Canada Vigilance
US FAERS
45Urine flow decreasedFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
46Visual ImpairmentFAERS: 16US FAERS
47ArthralgiaFAERS: 15US FAERS
48DysgeusiaFAERS: 15US FAERS
49AmnesiaFAERS: 14US FAERS
50Bladder spasmFAERS: 14US FAERS
51DiscomfortFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
52SyncopeFAERS: 14
Canada Vigilance: 2
Canada Vigilance
US FAERS
53VertigoFAERS: 14US FAERS
54ErythemaFAERS: 13US FAERS
55TachycardiaFAERS: 13US FAERS
56Eye painFAERS: 12US FAERS
57SwellingFAERS: 12
Canada Vigilance: 2
Canada Vigilance
US FAERS
58Weight decreasedFAERS: 12US FAERS
59Blood creatinine increasedFAERS: 11US FAERS
60Blood urine presentFAERS: 11
Canada Vigilance: 3
Canada Vigilance
US FAERS
61Drug dispensing errorFAERS: 11US FAERS
62No adverse eventFAERS: 11US FAERS
63PneumoniaFAERS: 11US FAERS
64TremorFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
65ArthropathyFAERS: 10US FAERS
66Atrial FibrillationFAERS: 10US FAERS
67Blood sodium decreasedFAERS: 10US FAERS
68DehydrationFAERS: 10US FAERS
69DiplopiaFAERS: 10US FAERS
70IncontinenceFAERS: 10US FAERS
71ThirstFAERS: 10US FAERS
72Wrong technique in product usage processFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
73AngioedemaFAERS: 9US FAERS
74AnxietyFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
75Blood glucose increasedFAERS: 9US FAERS
76Eye irritationFAERS: 9US FAERS
77Multiple SclerosisFAERS: 9US FAERS
78TinnitusFAERS: 9US FAERS
79nervous system disorderFAERS: 9US FAERS
80Chest discomfortFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
81Dry skinFAERS: 8US FAERS
82Intentional product misuseFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
83Middle insomniaFAERS: 8US FAERS
84Product quality issueFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
85Product use in unapproved indicationFAERS: 8US FAERS
86AgeusiaFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
87Blood potassium decreasedFAERS: 7US FAERS
88BradycardiaFAERS: 7US FAERS
89Drug dose omissionFAERS: 7US FAERS
90Drug ineffective for unapproved indicationFAERS: 7US FAERS
91Expired drug administeredFAERS: 7US FAERS
92InfluenzaFAERS: 7US FAERS
93MyalgiaFAERS: 7US FAERS
94Throat irritationFAERS: 7US FAERS
95AgitationFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
96ArthritisFAERS: 6US FAERS
97BlindnessFAERS: 6US FAERS
98Blood glucose decreasedFAERS: 6US FAERS
99Burning sensationFAERS: 6US FAERS
100Expired product administeredFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
101InfectionFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
102Intestinal ObstructionFAERS: 6US FAERS
103Peripheral swellingFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
104Therapeutic response unexpectedFAERS: 6US FAERS
105Urinary tract obstructionFAERS: 6
Canada Vigilance: 3
Canada Vigilance
US FAERS
106Urine output increasedFAERS: 6US FAERS
107AbasiaFAERS: 5US FAERS
108Angina PectorisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
109Angle Closure GlaucomaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
110Anticholinergic SyndromeFAERS: 5US FAERS
111AnuriaFAERS: 5US FAERS
112AphoniaFAERS: 5US FAERS
113Back disorderFAERS: 5US FAERS
114BronchitisFAERS: 5US FAERS
115CataractFAERS: 5US FAERS
116CryingFAERS: 5US FAERS
117Drug effect delayedFAERS: 5US FAERS
118Drug prescribing errorFAERS: 5US FAERS
119EructationFAERS: 5US FAERS
120FractureFAERS: 5US FAERS
121Intentional product use issueFAERS: 5US FAERS
122Joint injuryFAERS: 5US FAERS
123Joint swellingFAERS: 5US FAERS
124Pre-existing condition improvedFAERS: 5US FAERS
125Productive CoughFAERS: 5US FAERS
126Renal painFAERS: 5US FAERS
127WheezingFAERS: 5US FAERS
128Accidental overdoseFAERS: 4US FAERS
129AphasiaFAERS: 4US FAERS
130AsthmaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
131Blood cholesterol increasedFAERS: 4US FAERS
132ChillsFAERS: 4US FAERS
133ChromaturiaFAERS: 4US FAERS
134DeliriumFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
135Dental cariesFAERS: 4US FAERS
136Depressed moodFAERS: 4US FAERS
137DysgraphiaFAERS: 4US FAERS
138EnuresisFAERS: 4US FAERS
139HydronephrosisFAERS: 4US FAERS
140HypohidrosisFAERS: 4US FAERS
141IleusFAERS: 4US FAERS
142Medication ErrorFAERS: 4US FAERS
143Mouth BreathingFAERS: 4US FAERS
144NephrolithiasisFAERS: 4US FAERS
145Sjogren's SyndromeFAERS: 4US FAERS
146StomatitisFAERS: 4US FAERS
147StressFAERS: 4US FAERS
148Urinary hesitationFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
149AnosmiaFAERS: 3US FAERS
150AphagiaFAERS: 3US FAERS
151Blood potassium increasedFAERS: 3US FAERS
152Coronary Artery DiseaseFAERS: 3US FAERS
153CyanosisFAERS: 3US FAERS
154DeafnessFAERS: 3US FAERS
155Ear discomfortFAERS: 3US FAERS
156EpistaxisFAERS: 3US FAERS
157FlushingFAERS: 3US FAERS
158Head discomfortFAERS: 3US FAERS
159Impaired driving abilityFAERS: 3US FAERS
160IncoherentFAERS: 3US FAERS
161Ligament ruptureFAERS: 3US FAERS
162Loss of personal independence in daily activitiesFAERS: 3US FAERS
163Macular degenerationFAERS: 3US FAERS
164Nasal discomfortFAERS: 3US FAERS
165Neck PainFAERS: 3US FAERS
166NervousnessFAERS: 3US FAERS
167Oral pruritusFAERS: 3US FAERS
168PresyncopeFAERS: 3US FAERS
169Pulmonary arterial hypertensionFAERS: 3US FAERS
170Reaction to drug excipientsFAERS: 3US FAERS
171RestlessnessFAERS: 3US FAERS
172SciaticaFAERS: 3US FAERS
173Suspected counterfeit productFAERS: 3US FAERS
174Therapeutic response changedFAERS: 3US FAERS
175Therapy regimen changedFAERS: 3US FAERS
176Unevaluable eventFAERS: 3US FAERS
177AcidosisFAERS: 2US FAERS
178Activities of daily living impairedFAERS: 2US FAERS
179Anaphylactic shockFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
180Atypical pneumoniaFAERS: 2US FAERS
181Bladder discomfortFAERS: 2US FAERS
182Blood urea increasedFAERS: 2US FAERS
183Bone swellingFAERS: 2US FAERS
184BursitisFAERS: 2US FAERS
185Cardiac ArrestFAERS: 2US FAERS
186Cardiovascular insufficiencyFAERS: 2US FAERS
187Choking sensationFAERS: 2US FAERS
188ChokingFAERS: 2US FAERS
189ConjunctivitisFAERS: 2US FAERS
190Creatinine renal clearance decreasedFAERS: 2US FAERS
191DependenceFAERS: 2US FAERS
192Drug withdrawal syndromeFAERS: 2US FAERS
193DysarthriaFAERS: 2US FAERS
194Feeling ColdFAERS: 2US FAERS
195FibromyalgiaFAERS: 2US FAERS
196Food AllergyFAERS: 2US FAERS
197FrustrationFAERS: 2US FAERS
198Gastric BypassFAERS: 2US FAERS
199GastritisFAERS: 2US FAERS
200Gastrointestinal hypomotilityFAERS: 2US FAERS
201Gastrointestinal motility disorderFAERS: 2US FAERS
202General physical health deteriorationFAERS: 2US FAERS
203Genital infection fungalFAERS: 2US FAERS
204Genital painFAERS: 2US FAERS
205Genital rashFAERS: 2US FAERS
206HerniaFAERS: 2US FAERS
207HypersomniaFAERS: 2US FAERS
208HypophagiaFAERS: 2US FAERS
209Impaired gastric emptyingFAERS: 2US FAERS
210Increased upper airway secretionFAERS: 2US FAERS
211InflammationFAERS: 2US FAERS
212Large intestinal stenosisFAERS: 2US FAERS
213LaryngitisFAERS: 2US FAERS
214LethargyFAERS: 2US FAERS
215Limb discomfortFAERS: 2US FAERS
216LymphadenopathyFAERS: 2US FAERS
217Mastication disorderFAERS: 2US FAERS
218Mental impairmentFAERS: 2US FAERS
219Mood swingsFAERS: 2US FAERS
220Myocardial InfarctionFAERS: 2US FAERS
221Night sweatsFAERS: 2US FAERS
222Oropharyngeal blisteringFAERS: 2US FAERS
223Pain of skinFAERS: 2US FAERS
224Penile InfectionFAERS: 2US FAERS
225PolyuriaFAERS: 2US FAERS
226Poor quality sleepFAERS: 2US FAERS
227Postrenal failureFAERS: 2US FAERS
228Product dose omissionFAERS: 2US FAERS
229Pulmonary EmbolismFAERS: 2US FAERS
230PyelonephritisFAERS: 2US FAERS
231Rash erythematousFAERS: 2US FAERS
232RectoceleFAERS: 2US FAERS
233Semen volume decreasedFAERS: 2US FAERS
234SepsisFAERS: 2US FAERS
235SinusitisFAERS: 2US FAERS
236Skin lesionFAERS: 2US FAERS
237Skin reactionFAERS: 2US FAERS
238SneezingFAERS: 2US FAERS
239Sudden deathFAERS: 2US FAERS
240Therapeutic product effect incompleteFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
241Thermal burnFAERS: 2US FAERS
242Tongue spasmFAERS: 2US FAERS
243Transaminases increasedFAERS: 2US FAERS
244Urge IncontinenceFAERS: 2US FAERS
245AcneFAERS: 1US FAERS
246Acute kidney injuryFAERS: 1US FAERS
247Acute myocardial infarctionFAERS: 1US FAERS
248Adverse eventFAERS: 1US FAERS
249Alcohol interactionFAERS: 1US FAERS
250Ammonia increasedFAERS: 1US FAERS
251Amnestic DisorderFAERS: 1US FAERS
252Amphetamines positiveFAERS: 1US FAERS
253Amylase increasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
254Anal FissureFAERS: 1US FAERS
255Ankle FractureFAERS: 1US FAERS
256AnorgasmiaFAERS: 1US FAERS
257Apparent deathFAERS: 1US FAERS
258AppendicitisFAERS: 1US FAERS
259BedriddenFAERS: 1US FAERS
260Benign Prostatic HyperplasiaFAERS: 1US FAERS
261Bladder cystFAERS: 1US FAERS
262Bladder dysfunctionFAERS: 1US FAERS
263Bladder prolapseFAERS: 1US FAERS
264BlepharospasmFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
265Blood alkaline phosphatase increasedFAERS: 1US FAERS
266Blood creatine phosphokinase increasedFAERS: 1US FAERS
267Blood glucose abnormalFAERS: 1US FAERS
268Blood pressure fluctuationFAERS: 1US FAERS
269Breast tendernessFAERS: 1US FAERS
270BronchospasmFAERS: 1US FAERS
271BruxismFAERS: 1US FAERS
272Cardiac FlutterFAERS: 1US FAERS
273Catheter placementFAERS: 1US FAERS
274Cerebral InfarctionFAERS: 1US FAERS
275CheilitisFAERS: 1US FAERS
276Circumstance or information capable of leading to medication errorFAERS: 1US FAERS
277Cold sweatFAERS: 1US FAERS
278Completed SuicideFAERS: 1US FAERS
279Creatinine renal clearance increasedFAERS: 1US FAERS
280CystFAERS: 1US FAERS
281Dacryostenosis acquiredFAERS: 1US FAERS
282Deafness NeurosensoryFAERS: 1US FAERS
283Depressed Level of ConsciousnessFAERS: 1US FAERS
284Depression suicidalFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
285Disease ProgressionFAERS: 1US FAERS
286Drug administration errorFAERS: 1US FAERS
287Drug effect variableFAERS: 1US FAERS
288Drug effective for unapproved indicationFAERS: 1US FAERS
289Drug screen false positiveFAERS: 1US FAERS
290Drug screen positiveFAERS: 1US FAERS
291DyscheziaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
292DyspareuniaFAERS: 1US FAERS
293Economic problemFAERS: 1US FAERS
294Ectopic PregnancyFAERS: 1US FAERS
295EczemaFAERS: 1US FAERS
296EmbolismFAERS: 1US FAERS
297Emotional distressFAERS: 1US FAERS
298Epigastric discomfortFAERS: 1US FAERS
299EpilepsyFAERS: 1US FAERS
300Erectile dysfunctionFAERS: 1US FAERS
301Erythema MultiformeFAERS: 1US FAERS
302Escherichia infectionFAERS: 1US FAERS
303Escherichia sepsisFAERS: 1US FAERS
304Euphoric moodFAERS: 1US FAERS
305Extra dose administeredFAERS: 1US FAERS
306Eye BurnsFAERS: 1US FAERS
307Food PoisoningFAERS: 1US FAERS
308Gait inabilityFAERS: 1US FAERS
309Gallbladder painFAERS: 1US FAERS
310Gastric ulcerFAERS: 1US FAERS
311Gastrointestinal PainFAERS: 1US FAERS
312GoutFAERS: 1US FAERS
313HepatitisFAERS: 1US FAERS
314HepatomegalyFAERS: 1US FAERS
315Hip surgeryFAERS: 1US FAERS
316HungerFAERS: 1US FAERS
317HyperacusisFAERS: 1US FAERS
318HyperchlorhydriaFAERS: 1US FAERS
319HyperkeratosisFAERS: 1US FAERS
320HypomaniaFAERS: 1US FAERS
321Hypotonic urinary bladderFAERS: 1US FAERS
322HypoxiaFAERS: 1US FAERS
323Impaired work abilityFAERS: 1US FAERS
324Incorrect drug administration durationFAERS: 1US FAERS
325Infective spondylitisFAERS: 1US FAERS
326Intentional dose omissionFAERS: 1US FAERS
327Intentional drug misuseFAERS: 1US FAERS
328Intercepted drug prescribing errorFAERS: 1US FAERS
329Intervertebral disc disorderFAERS: 1US FAERS
330Intraocular pressure fluctuationFAERS: 1US FAERS
331Irritable Bowel SyndromeFAERS: 1US FAERS
332Joint InstabilityFAERS: 1US FAERS
333Joint Range of Motion DecreasedFAERS: 1US FAERS
334LacerationFAERS: 1US FAERS
335Lactose IntoleranceFAERS: 1US FAERS
336Lip exfoliationFAERS: 1US FAERS
337Lower respiratory tract infectionFAERS: 1US FAERS
338LymphomaFAERS: 1US FAERS
339MalabsorptionFAERS: 1US FAERS
340Male Orgasmic DisorderFAERS: 1US FAERS
341MastectomyFAERS: 1US FAERS
342Medication residueFAERS: 1US FAERS
343Medication residue presentFAERS: 1US FAERS
344MenorrhagiaFAERS: 1US FAERS
345MetamorphopsiaFAERS: 1US FAERS
346Migraine with AuraFAERS: 1US FAERS
347Milk AllergyFAERS: 1US FAERS
348Motion SicknessFAERS: 1US FAERS
349Mouth swellingFAERS: 1US FAERS
350Moyamoya DiseaseFAERS: 1US FAERS
351Multiple System AtrophyFAERS: 1US FAERS
352Musculoskeletal chest painFAERS: 1US FAERS
353Musculoskeletal discomfortFAERS: 1US FAERS
354Myasthenia GravisFAERS: 1US FAERS
355MyositisFAERS: 1US FAERS
356Nephrotic SyndromeFAERS: 1US FAERS
357Nipple painFAERS: 1US FAERS
358ObesityFAERS: 1US FAERS
359Ocular discomfortFAERS: 1US FAERS
360OliguriaFAERS: 1US FAERS
361OnychoclasisFAERS: 1US FAERS
362Oropharyngeal discomfortFAERS: 1US FAERS
363Orthostatic hypertensionFAERS: 1US FAERS
364OsteoporosisFAERS: 1US FAERS
365OverdoseFAERS: 1US FAERS
366OverweightFAERS: 1US FAERS
367Palliative CareFAERS: 1US FAERS
368PancreatitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
369Pelvic PainFAERS: 1US FAERS
370Pelvic massFAERS: 1US FAERS
371Peritoneal DialysisFAERS: 1US FAERS
372Personality ChangeFAERS: 1US FAERS
373Physical assaultFAERS: 1US FAERS
374Physical product label issueFAERS: 1US FAERS
375Pneumatosis intestinalisFAERS: 1US FAERS
376Prescribed overdoseFAERS: 1US FAERS
377ProctitisFAERS: 1US FAERS
378Product blister packaging issueFAERS: 1US FAERS
379Product communication issueFAERS: 1US FAERS
380Product label issueFAERS: 1US FAERS
381Product lot number issueFAERS: 1US FAERS
382Product packaging issueFAERS: 1US FAERS
383Product physical issueFAERS: 1US FAERS
384Proteus test positiveFAERS: 1US FAERS
385PsoriasisFAERS: 1US FAERS
386PyelocaliectasisFAERS: 1US FAERS
387RalesFAERS: 1US FAERS
388Rectal ProlapseFAERS: 1US FAERS
389Renal cystFAERS: 1US FAERS
390Renal massFAERS: 1US FAERS
391Residual urine volume increasedFAERS: 1US FAERS
392Residual urineFAERS: 1US FAERS
393Respiratory arrestFAERS: 1US FAERS
394Restless Legs SyndromeFAERS: 1US FAERS
395RetchingFAERS: 1US FAERS
396Retinal DetachmentFAERS: 1US FAERS
397ScabFAERS: 1US FAERS
398Sexual DysfunctionFAERS: 1US FAERS
399Skin lacerationFAERS: 1US FAERS
400Sleep disorder due to general medical condition, insomnia typeFAERS: 1US FAERS
401SomnambulismFAERS: 1US FAERS
402SpondylitisFAERS: 1US FAERS
403Stevens-Johnson SyndromeFAERS: 1US FAERS
404StrabismusFAERS: 1US FAERS
405Temperature intoleranceFAERS: 1US FAERS
406TensionFAERS: 1US FAERS
407Terminal stateFAERS: 1US FAERS
408Therapeutic product effect delayedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
409ThrombocytopeniaFAERS: 1US FAERS
410ThrombosisFAERS: 1US FAERS
411Tongue blisteringFAERS: 1US FAERS
412Tongue exfoliationFAERS: 1US FAERS
413Tooth ExtractionFAERS: 1US FAERS
414Tooth LossFAERS: 1US FAERS
415ToothacheFAERS: 1US FAERS
416Troponin increasedFAERS: 1US FAERS
417Urethral StenosisFAERS: 1US FAERS
418Urethritis noninfectiveFAERS: 1US FAERS
419Urinary Tract PainFAERS: 1US FAERS
420Vaginal lesionFAERS: 1US FAERS
421VasculitisFAERS: 1US FAERS
422Viral upper respiratory tract infectionFAERS: 1US FAERS
423Vitreous floatersFAERS: 1US FAERS
424Vocal Cord ParalysisFAERS: 1US FAERS
425Vulvovaginal discomfortFAERS: 1US FAERS
426Vulvovaginal drynessFAERS: 1US FAERS
427Vulvovaginal painFAERS: 1US FAERS
428Vulvovaginal pruritusFAERS: 1US FAERS
429Walking aid userFAERS: 1US FAERS
430White blood cell count abnormalFAERS: 1US FAERS
431White blood cell count decreasedFAERS: 1US FAERS
432XerophthalmiaFAERS: 1US FAERS
433prostatitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
434pseudomembranous colitisFAERS: 1US FAERS
435Accidental exposure to productCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.